| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Minerva Neurosciences, Inc. (NERV) has 8 insiders with recent SEC Form 4 filings, including 3 buys and 10 sells. NERV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.25M | $13.23M | - | |
| Pres | 1.50M | $8.82M | - | |
| CFO | 500.0K | $2.94M | - | |
| Dir | 364.5K | $2.14M | - | |
| Dir | 50.0K | $294.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2017 | Race Geoff | EVP, CFO &Cbo | Sell | 21,450 | $11.02 | $236,345.16 | -5.5% | |
| Feb 6, 2017 | Luthringer Remy | President &CEO | Sale+OE | 34,281 | $11.02 | $377,732.92 | -100% | |
| Jan 11, 2017 | Reilly Joseph H. | SVP &Chief Operating Officer | Sale+OE | 1,600 | $12.03 | $19,248.00 | -16.1% | |
| Jan 4, 2017 | Levine Mark S.66 | SVP,General Counsel &Sec. | Sale+OE | 17,500 | $12.00 | $210,000.00 | -100% | |
| Dec 27, 2016 | Ahlholm Frederick W | SVP, Chief Accounting Officer | Sale+OE | 17,000 | $12.51 | $212,670.00 | -77.3% | |
| Aug 10, 2016 | Index Venture Associates III Ltd | 10% Owner | Sell | 1,000,000 | $10.00 | $10,000,000.00 | -18.2% | |
| Aug 10, 2016 | Ollier Michele | Director, 10% Owner | Sell | 1,000,000 | $10.00 | $10,000,000.00 | -18.2% | |
| Aug 10, 2016 | De Rubertis Francesco | Director, 10% Owner | Sell | 1,000,000 | $10.00 | $10,000,000.00 | -18.2% | |
| Jun 21, 2016 | Kupfer David | Director | Buy | 55,635 | $10.84 | $603,000.98 | +30.7% | |
| Mar 17, 2016 | Kupfer David | Director | Buy | 181,488 | $5.51 | $999,998.88 | New |